Select a Sector or Industry
Gross Profit TTM Rankings for Biotechnology Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Gross Profit TTM
|
Pro Rating
|
|---|---|---|---|---|
| 1 | AMGN | Amgen | 13.38B | Go Pro |
| 2 | GILD | Gilead Sciences | 6.511B | Go Pro |
| 3 | BIIB | Biogen Idec | 4.640B | Go Pro |
| 4 | CELG | Celgene Corporation | 4.619B | Go Pro |
| 5 | SHPGY | Shire | 3.841B | Go Pro |
| 6 | VRTX | Vertex Pharmaceuticals | 1.659B | Go Pro |
| 7 | ALXN | Alexion Pharmaceuticals | 759.86M | Go Pro |
| 8 | ILMN | Illumina | 714.16M | Go Pro |
| 9 | AMLN | Amylin Pharmaceuticals | 581.26M | Go Pro |
| 10 | REGN | Regeneron Pharmaceuticals | 549.28M | Go Pro |
| 11 | VPHM | ViroPharma | 459.95M | Go Pro |
| 12 | ONXX | ONYX Pharmaceuticals | 452.06M | Go Pro |
| 13 | CRL | Charles River Laboratories International | 403.82M | Go Pro |
| 14 | BMRN | BioMarin Pharmaceutical | 368.22M | Go Pro |
| 15 | PDLI | PDL BioPharma | 356.05M | Go Pro |
| 16 | JAZZ | Jazz Pharmaceuticals | 307.92M | Go Pro |
| 17 | EXEL | Exelixis | 272.25M | Go Pro |
| 18 | QCOR | Questcor Pharmaceuticals | 261.20M | Go Pro |
| 19 | EBS | Emergent BioSolutions | 256.55M | Go Pro |
| 20 | ACOR | Acorda Therapeutics | 235.22M | Go Pro |
| 21 | MNTA | Momenta Pharmaceuticals | 229.12M | Go Pro |
| 22 | DNDN | Dendreon Corporation | 195.87M | Go Pro |
| 23 | SPPI | Spectrum Pharmaceuticals | 173.29M | Go Pro |
| 24 | THRX | Theravance | 145.28M | Go Pro |
| 25 | SGEN | Seattle Genetics | 124.67M | Go Pro |
| 26 | CBPO | China Biologic Products | 107.08M | Go Pro |
| 27 | NPSP | NPS Pharmaceuticals | 100.49M | Go Pro |
| 28 | SNTS | Santarus | 98.70M | Go Pro |
| 29 | INCY | Incyte Corporation | 98.65M | Go Pro |
| 30 | AFFY | Affymax | 94.25M | Go Pro |
| 31 | OMPI | Obagi Medical Products | 93.55M | Go Pro |
| 32 | INFI | Infinity Pharmaceuticals | 90.79M | Go Pro |
| 33 | PGNX | Progenics Pharmaceuticals | 84.63M | Go Pro |
| 34 | OPTR | Optimer Pharmaceuticals | 82.96M | Go Pro |
| 35 | MDVN | Medivation | 82.50M | Go Pro |
| 36 | ALNY | Alnylam Pharmaceuticals | 82.45M | Go Pro |
| 37 | SSRX | 3SBio | 82.09M | Go Pro |
| 38 | CDXS | Codexis | 82.08M | Go Pro |
| 39 | TRGT | Targacept | 81.50M | Go Pro |
| 40 | CBM | Cambrex Corporation | 79.06M | Go Pro |
| 41 | NBIX | Neurocrine Biosciences | 76.17M | Go Pro |
| 42 | HGSI | Human Genome Sciences | 69.29M | Go Pro |
| 43 | RELV | Reliv' International | 61.06M | Go Pro |
| 44 | ARRY | Array BioPharma | 57.88M | Go Pro |
| 45 | CRTX | Cornerstone Therapeutics | 57.11M | Go Pro |
| 46 | HALO | Halozyme Therapeutics | 55.67M | Go Pro |
| 47 | XNPT | XenoPort | 53.52M | Go Pro |
| 48 | XOMA | XOMA Corporation | 52.47M | Go Pro |
| 49 | NKTR | Nektar Therapeutics | 50.80M | Go Pro |
| 50 | DYAX | Dyax | 50.49M | Go Pro |
